genXone

genXone SA successfully completed a private subscription. The company raised 4.14 million PLN (the originally planned amount was 2 million PLN). The purpose of the emission was to raise funds to finance the company’s current operations, including commercialization of the latest NANOBIOME project, which aims to perform advanced research on the human intestinal bacteria.

23 September 2022

genXone & gMendel join forces in diagnostics of genetic disorders

Biotech company genXone has signed a letter of intent to significantly expand its cooperation with Danish gMendel®. The joint efforts of two companies began earlier this year, with trial project for the diagnosis of genetic disorders. The current phase begins with negotiations on an investment agreement and the expected result is the innovative tool for […]

7 September 2022

Polish-Danish Life Science Business Seminar

On the 6th of September 2022, at the Foreign Trade Office of the Polish Investment and Trade Agency HQ in Copenhagen, R&D Director Prof. Lukasz Krych spoke about our company and the cooperation that genXone has with various institutions based in Denmark. The main purpose of the seminar was to initiate a debate on the […]

27 May 2022

News

Yesterday (26 May 2022), Vice President Jolanta Kołodziejczyk participated in CEBioForum 2022. It was a great pleasure to receive the Anti-Covid Solution Award. Thank you very much! Congratulaions to the organizers of a very successful event! Today we participate in the conference “Prehabilitacja 2022 – to działa“. It is a fantastic experience to listen to […]

16 May 2022

XI Scientific and Training Conference “Public Health Threats”

It is a great pleasure to invite you to follow the XI Scientific and Training Conference “Public Health Threats”, which will be held in Pisz, on 23-25 May 2022. The conference will summarize activities from the pandemic period in Poland. On the first day in the panel: Substantive Session Part 1 “COVID-19 … and what […]

13 May 2022

More than 37 percent revenue growth for genXone in first quarter of 2022

Press Release Biotechnology company genXone has achieved in the first quarter of this year an impressive, over 37 percent increase in revenue. From January to the end of March this year it was over PLN 7.3 million, while a year earlier it was about PLN 5.3 million. Net profit in the first quarter of this […]

4 May 2022

“Smart Specialization for Wielkopolska” award ceremony

Representatives of genXone received an award in the XIV edition of the Competition for the Marshal of the Wielkopolska Region Award “i-Wielkopolska – Innovative for Wielkopolska”. The ceremony of honoring the winners of the 2021 edition of the Competition took place on April 25, 2022, during the session of the Assembly of the Wielkopolska Region. […]